There are 717 resources available
Immunotherapy biomarkers: What should we be prepared to assess beyond PDL1?
Presenter: Caicun Zhou
Session: Are large NGS panels really changing patient outcomes?
Resources:
Slides
Webcast
Novel clinical trial designs
Presenter: Urania Dafni
Session: Innovation in oncology drug development and regulation (in collaboration with CSCO)
Resources:
Slides
Webcast
Bottleneck, coping strategy and expectation: Anti-angiogenic therapy in China
Presenter: Kai Li
Session: Innovation in oncology drug development and regulation (in collaboration with CSCO)
Resources:
Slides
Webcast
Registration-class real world evidence for oncology drug approval: Utopia or promise?
Presenter: Miriam Koopman
Session: Innovation in oncology drug development and regulation (in collaboration with CSCO)
Resources:
Slides
Webcast
Open and welcome
Presenter: Alex A. Adjei
Session: Hopes and limitations for CRISPR technology in cancer (in collaboration with AACR)
Resources:
Slides
Webcast
CRISPR as a tool for rational design of drug combinations
Presenter: Rene Bernards
Session: Hopes and limitations for CRISPR technology in cancer (in collaboration with AACR)
Resources:
Slides
Webcast
CRISPR in the Clinic: CRISPR-edited T cells for lung cancer therapy
Presenter: You Lu
Session: Hopes and limitations for CRISPR technology in cancer (in collaboration with AACR)
Resources:
Slides
Webcast
CRISPR-edited CAR T cells
Presenter: Michel Sadelain
Session: Hopes and limitations for CRISPR technology in cancer (in collaboration with AACR)
Resources:
Slides
Webcast
CRISPR screens identify novel targets regulating tumor immune microenvironment
Presenter: Xiaole Shirley Liu
Session: Hopes and limitations for CRISPR technology in cancer (in collaboration with AACR)
Resources:
Webcast
Conclusion
Presenter: Michel Sadelain
Session: Hopes and limitations for CRISPR technology in cancer (in collaboration with AACR)
Resources:
Slides
Webcast